Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.67056 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.58736 | 60 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.60926 | 60 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.6797 | 62 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.52093 | 59 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.76211 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.83227 | 63 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.68264 | 62 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.54575 | 59 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.79001 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.5996 | 60 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.53646 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.6215 | 60 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.63257 | 61 |